The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD.
Engelfriet CP, et al. Among authors: berntorp e.
Vox Sang. 2000;78(4):256-61.
Vox Sang. 2000.
PMID: 10970234
No abstract available.